99 related articles for article (PubMed ID: 18227840)
1. Engineering human tumor-specific cytotoxic T cells to function in a hypoxic environment.
Kim H; Peng G; Hicks JM; Weiss HL; Van Meir EG; Brenner MK; Yotnda P
Mol Ther; 2008 Mar; 16(3):599-606. PubMed ID: 18227840
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of the antigen-specific cytotoxic T lymphocyte-inducing ability in the PMDC11 leukemic plasmacytoid dendritic cell line via lentiviral vector-mediated transduction of the caTLR4 gene.
Iwabuchi M; Narita M; Uchiyama T; Iwaya S; Oiwa E; Nishizawa Y; Hashimoto S; Bonehill A; Kasahara N; Takizawa J; Takahashi M
Mol Med Rep; 2015 Aug; 12(2):2443-50. PubMed ID: 25936433
[TBL] [Abstract][Full Text] [Related]
3. Construction of expression vector of hTERT- hIL18 fusion gene and induction of cytotoxic T lymphocyte response against hTERT.
Tong XM; Zheng SE; Bader A; Yao HP; Wu NP; Altmeyer P; Brockmeyer NH; Jin J
Eur J Med Res; 2008 Jan; 13(1):7-14. PubMed ID: 18226991
[TBL] [Abstract][Full Text] [Related]
4. Bcl-2 silencing attenuates hypoxia-induced apoptosis resistance in pulmonary microvascular endothelial cells.
Cao Y; Jiang Z; Zeng Z; Liu Y; Gu Y; Ji Y; Zhao Y; Li Y
Apoptosis; 2016 Jan; 21(1):69-84. PubMed ID: 26456506
[TBL] [Abstract][Full Text] [Related]
5. Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes.
Takahashi S; Rousseau RF; Yotnda P; Mei Z; Dotti G; Rill D; Hurwitz R; Marini F; Andreeff M; Brenner MK
Hum Gene Ther; 2001 Apr; 12(6):659-70. PubMed ID: 11426465
[TBL] [Abstract][Full Text] [Related]
6. Transgenic expression of CD40L and interleukin-2 induces an autologous antitumor immune response in patients with non-Hodgkin's lymphoma.
Takahashi S; Yotnda P; Rousseau RF; Mei Z; Smith S; Rill D; Younes A; Brenner MK
Cancer Gene Ther; 2001 May; 8(5):378-87. PubMed ID: 11477458
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-responsive element-mediated soluble Tie2 vector exhibits an anti-angiogenic activity in vitro under hypoxic condition.
Jeong CH; Lee YM; Choi KS; Seong YR; Kim YJ; Im DS; Kim KW
Int J Oncol; 2005 Jan; 26(1):211-6. PubMed ID: 15586242
[TBL] [Abstract][Full Text] [Related]
8. IL-2/B7.1 (CD80) fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: a strategy to generate whole cell vaccines for AML.
Chan L; Hardwick N; Darling D; Galea-Lauri J; Gäken J; Devereux S; Kemeny M; Mufti G; Farzaneh F
Mol Ther; 2005 Jan; 11(1):120-31. PubMed ID: 15585413
[TBL] [Abstract][Full Text] [Related]
9. Activation of human dendritic cells by recombinant modified vaccinia virus Ankara vectors encoding survivin and IL-2 genes in vitro.
Tao R; Li L; Huang W; Zheng L
Hum Gene Ther; 2010 Jan; 21(1):98-108. PubMed ID: 19715401
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory activity.
Joseph A; Zheng JH; Follenzi A; Dilorenzo T; Sango K; Hyman J; Chen K; Piechocka-Trocha A; Brander C; Hooijberg E; Vignali DA; Walker BD; Goldstein H
J Virol; 2008 Mar; 82(6):3078-89. PubMed ID: 18184707
[TBL] [Abstract][Full Text] [Related]
11. Generation of bidirectional hypoxia/HIF-responsive expression vectors to target gene expression to hypoxic cells.
Post DE; Van Meir EG
Gene Ther; 2001 Dec; 8(23):1801-7. PubMed ID: 11803400
[TBL] [Abstract][Full Text] [Related]
12. Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes.
Quintarelli C; Vera JF; Savoldo B; Giordano Attianese GM; Pule M; Foster AE; Heslop HE; Rooney CM; Brenner MK; Dotti G
Blood; 2007 Oct; 110(8):2793-802. PubMed ID: 17638856
[TBL] [Abstract][Full Text] [Related]
13. Design and in vivo characterization of self-inactivating human and non-human lentiviral expression vectors engineered for streptogramin-adjustable transgene expression.
Mitta B; Weber CC; Rimann M; Fussenegger M
Nucleic Acids Res; 2004 Jul; 32(12):e106. PubMed ID: 15258250
[TBL] [Abstract][Full Text] [Related]
14. Effects of extracellular pH and hypoxia on the function and development of antigen-specific cytotoxic T lymphocytes.
Nakagawa Y; Negishi Y; Shimizu M; Takahashi M; Ichikawa M; Takahashi H
Immunol Lett; 2015 Oct; 167(2):72-86. PubMed ID: 26209187
[TBL] [Abstract][Full Text] [Related]
15. [Hypoxia responsive element regulated herpes simplex virus-thymidine kinase system enhances killing effect of gancyclovir on Ewing's sarcoma cell line under hypoxic condition].
Si YJ; Guang LX; Yuan FH; Zhang KB
Zhonghua Er Ke Za Zhi; 2006 Aug; 44(8):616-20. PubMed ID: 17083794
[TBL] [Abstract][Full Text] [Related]
16. [Targeted inhibition of vascular endothelial growth factor (VEGF) expression in human osteosarcoma cell line by antisense VEGF165 cDNA promoted by hypoxia reaction element].
Wang Y; Wang R; Qiao H; Li JY; Peng TS; Li Y; Zhang M; Liang HZ; Qiu JS
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):588-91. PubMed ID: 16468311
[TBL] [Abstract][Full Text] [Related]
17. Lentivirus-mediated gene transfer and expression in established human tumor antigen-specific cytotoxic T cells and primary unstimulated T cells.
Zhou X; Cui Y; Huang X; Yu Z; Thomas AM; Ye Z; Pardoll DM; Jaffee EM; Cheng L
Hum Gene Ther; 2003 Jul; 14(11):1089-105. PubMed ID: 12885348
[TBL] [Abstract][Full Text] [Related]
18. Lentivirally transduced dendritic cells as a tool for cancer immunotherapy.
Breckpot K; Dullaers M; Bonehill A; van Meirvenne S; Heirman C; de Greef C; van der Bruggen P; Thielemans K
J Gene Med; 2003 Aug; 5(8):654-67. PubMed ID: 12898635
[TBL] [Abstract][Full Text] [Related]
19. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
[TBL] [Abstract][Full Text] [Related]
20. Reduced tumorigenesis of EG7 after interleukin-10 gene transfer and enhanced efficacy in combination with intratumorally injection of adenovirus-mediated lymphotactin and the underlying mechanism.
Zhang J; Zhou Z; Wang C; Shen J; Zheng Y; Zhang L; Wang J; Xia D
Cancer Immunol Immunother; 2011 Apr; 60(4):559-73. PubMed ID: 21240488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
